Industry perspectives on market access of innovative drugs
This study presents industry perspectives on the challenges related to market access of innovative drugs in general and oncology drugs in specific. Fifteen interviews were conducted with representatives of pharmaceutical companies and industry associations. Interviewees call for a broader recognitio...
Saved in:
Main Authors: | Kim ePauwels (Author), Isabelle eHuys (Author), Minne eCasteels (Author), Steven eSimoens (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Towards a European definition for a drug shortage: a qualitative study
by: Elfi eDe Weerdt, et al.
Published: (2015) -
Time Investment in Drug Supply Problems by Flemish Community Pharmacies
by: Elfi De Weerdt, et al.
Published: (2017) -
Financial based agreements and performance based agreements: the Belgian experience
by: Kim Pauwels, et al.
Published: (2015) -
Valorising and creating access to innovative medicines in the European Union
by: Lieven eAnnemans, et al.
Published: (2011) -
Emerging Insights into European Markets of Biologics, Including Biosimilars
by: Steven Simoens, et al.
Published: (2022)